Healthcare Pharmaceutical Biotech

FBI Curaleaf Report Signals Federal Scrutiny Ahead for State Marijuana Operators Seeking DEA Registration

August 13, 2026 7:25 PM

MMJ International Holdings, Inc. ("MMJ") today said newly published reporting concerning a past FBI investigation involving Curaleaf illustrates the level of federal scrutiny that state-licensed marijuana operators could encounter as they seek registration from the Drug Enforcement Administration. According to an August 11 investigation published by The Newsground, FBI records obtained through the Freedom of Information Act show that federal...

Read more

Vogenx Announces Closing of Initial Public Offering

August 13, 2026 4:35 PM

Vogenx, Inc. (NASDAQ:VOGX) ("Vogenx"), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis, today announced the closing of its initial public offering of 6,250,000 shares of its common stock at a public offering price of $13.00 per share. All of...

Read more

Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights

August 13, 2026 4:15 PM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on complex pain, today reported financial and operational results for the second quarter ended June 30, 2026. On August 6, 2026, we completed the acquisition of Cy Biopharma, Inc. ("Cy Biopharma") with private placement financings of $38.6 million,...

Read more

Tenon Medical Reports Second Quarter 2026 Financial Results

August 13, 2026 4:05 PM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today reported financial results for the second quarter ended June 30, 2026. Financial Results and Business Updates Second Quarter 2026 Results: Second quarter revenue of $1.3 million, an increase of 127% compared to $0.6 million in the second quarter of 2025. Second...

Read more

Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds

August 13, 2026 4:05 PM

Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today closed its previously announced warrant inducement transaction with certain holders of its existing common warrants (the "Existing Warrants"), pursuant to which such holders have exercised in full for cash their Existing Warrants to purchase up to an aggregate of 254,922...

Read more

CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results

August 13, 2026 4:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2026. Second Quarter 2026 and Recent Financial, Operating and Regulatory Highlights Generated revenue of $3.0 million for the second quarter 2026 compared to...

Read more

Dr. Louis DeJoseph Outlines Important Considerations for Neck Lift Candidates

August 13, 2026 1:00 PM

The neck is among the first areas to show age, and it is almost always visible. Dr. Louis DeJoseph, a triple board-certified facial plastic surgeon at Premier Image Cosmetic & Laser Surgery in Atlanta, has outlined the signs that suggest someone may be a candidate for neck lift surgery, along with what patients should look for when selecting a surgeon. The Signs That Point Toward a Neck Lift Dr. DeJoseph points to several signs that suggest...

Read more

Brookside Multicare Nursing Center Earns CMS 5-Star Overall Quality Rating

August 13, 2026 12:30 PM

Brookside Multicare Nursing Center is proud to announce that it has earned the Overall Five-Star Quality Rating from the Centers for Medicare & Medicaid Services (CMS), the highest overall rating awarded through CMS's Five-Star Quality Rating System. This achievement reflects Brookside's unwavering commitment to clinical excellence, compassionate care, and exceptional outcomes for its residents. The CMS Five-Star Quality Rating System is one of...

Read more

Alter Behavioral Health Plans Q4 2026 San Diego Expansion in Response to Increased Demand

August 13, 2026 11:00 AM

Alter Behavioral Health today announced plans to expand its San Diego presence in Q4 2026 in response to increased demand for the organization's mental health services. Alter currently provides crisis stabilization and residential mental health treatment for adults in San Diego, along with consultation for partial hospitalization and intensive outpatient programs. The planned expansion reflects the organization's continued growth in the region...

Read more

CVS Health Enhances Its Direct-to-Consumer Weight Management Offerings To Improve Access, Affordability, Care and Support for GLP-1 Medications

August 13, 2026 10:30 AM

Originally published on CVS Health Company Newsroom CVS Pharmacy offers all FDA approved GLP-1s, whether through insurance or cash-pay options. New collaboration with Eli Lilly and Company will provide eligible Zepbound and Foundayo patients an additional access point at CVS Pharmacy through the CVS Health app MinuteClinic digital weight loss visits lowered to $29, the most affordable option in the market, available 24/7 Combines an online visit...

Read more

Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase

August 13, 2026 10:00 AM

Valion Bio, Inc. (Nasdaq:VBIO), a clinical-stage immunotherapeutics company, today announced that Ukraine's Ministry of Health has accepted the Company's regulatory dossier for Entolimod for formal review under the country's Regulatory Equivalence Pathway. Entolimod is Valion Bio's investigational medical countermeasure for acute radiation syndrome (ARS). The dossier was accepted on July 22, 2026. The Ministry has since begun technical...

Read more

MDCE Highlights StrainScan Pro for Multi-Billion-Dollar Cannabis Dispensary Sector with Enterprise iPad Air Solution (OTC Pink:MDCE)

August 13, 2026 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted the application of its already-launched StrainScan Pro platform for licensed cannabis dispensary operators, offering proprietary AI-powered visual identification and quality verification software designed for deployment on iPad Air devices. StrainScan Pro is a proprietary computer-vision software platform. Medical Care Technologies develops and commercializes AI vision technology...

Read more

RenX Enterprises Corp. Reports Second Quarter 2026 Results: Record Quarterly Revenue of $4.26 Million, Logistics Segment Profitable for Second Consecutive Quarter

August 13, 2026 9:00 AM

RenX Enterprises Corp. (NASDAQ:RENX) announced financial results for the three and six months ended June 30, 2026. The second quarter included three significant achievements: (i) record revenue, with the Company's two primary operating segments delivering sequential revenue growth, (ii) a second consecutive profitable quarter at the Logistics segment, and (iii) decisive progress on the Microtec UTM 1200 Turbo Mill, the initiative management...

Read more

BODYWELLE Brings Professional Football-Level Recovery to Miami Beach With EMSculpt NEO

August 13, 2026 9:00 AM

In June, BTL Industries announced a collaboration with the Dallas Cowboys, under which the team incorporated EMSCULPT NEO® into its athlete recovery and conditioning program. The announcement drew attention to a use of the technology that has developed alongside its better-known cosmetic applications, namely muscle activation and rehabilitation support. BODYWELLE, a physician-led longevity and functional medicine practice in Miami Beach, has...

Read more

Valiora Ingredients and Side Effects 2026: Already Eating Better and Staying Active? See Why This Once-Daily Formula is Getting a Closer Look

August 13, 2026 8:55 AM

Quick disclosure before you read further: this is a paid advertorial. This content is promotional in nature and is intended for consumer education regarding a commercially available product. A commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. Valiora is a dietary supplement - not a drug, not FDA-approved, and per the brand's own disclaimer, not...

Read more

BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update

August 13, 2026 8:35 AM

BioAdaptives, Inc. (OTCID:BDPT) announced a shareholder update on its current capital restructuring, adjustments in executive equity, and long-term operational strategies. As the company begins a crucial operational phase with the commercial launch of the XcellaraHeart™ wellness formulation, the Board of Directors and executive leadership have taken several steps to stabilize the equity structure, enhance liquidity, and safeguard the interests...

Read more

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

August 13, 2026 8:15 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced that management will be present and host one-on-one meetings with investors at Sidoti & Company's Micro-Cap Virtual Investor Conference taking place on August 19-20, 2026. Management plans to discuss its clinical and commercial development pipeline and its recently closed acquisition of Dura Driver Control Systems, a leading global automotive supplier with...

Read more

Military Health IT Enters Its Post-EHR Era as AI, Readiness and Battlefield Care Drive the Next Federal Technology Wave

August 13, 2026 7:30 AM

Black Book Market Research today announced the release of the State of U.S. Military and Defense Health Information Technology 2026, the thirteenth independent assessment of the federal military, defense and veterans healthcare technology market following the worldwide deployment of MHS GENESIS. The report draws on 1,037 survey replies received by Black Book and an 813-respondent analytical cohort representing military health, federal...

Read more

Healthcare Machine Learning Hits Production Scale as Governance Falls Behind, Black Book's Fourth Annual Report Finds

August 13, 2026 6:40 AM

Black Book Research today released its fourth annual healthcare machine learning study, The State of Healthcare Machine Learning 2026: U.S.-EU Adoption, Innovation, Assurance and 2027 Demand Outlook. The report tracks the transition from experimentation to sustained clinical, administrative and operational use across the United States and European Union. Based on 230 senior healthcare ML leaders (130 in the United States and 100 across 12 EU...

Read more

Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform

August 13, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic solutions for equine and companion animals, today announced a collaboration with Boehringer Ingelheim Animal Health Canada Inc., a leader in the animal health industry, to enhance the early detection, treatment, and monitoring of pituitary pars intermedia dysfunction (PPID) in horses across Canada. Through this initiative,...

Read more